Muscle-Invasive Bladder Cancer: Who Are the Ideal Candidates for Bladder Preservation and How Do Outcomes Compare to Radical Cystectomy / Therapy for Patients w/ Medically Inoperable Disease and How to Improve Tolerability of Treatment?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Muscle-Invasive Bladder Cancer: Who Are the Ideal Candidates for Bladder Preservation and How Do Outcomes Compare to Radical Cystectomy / Therapy for Patients w/ Medically Inoperable Disease and How to Improve Tolerability of Treatment?

By Fox Chase Updates in Bladder and Kidney Cancer 2019 FEATURING Mark A. Hallman

440 views

November 22, 2019

Mark A. Hallman, MD, PhD, Fox Chase Cancer Center, Philadelphia, PA

Dr. Hallman is an ...
read more ↘ Assistant Professor in the Department of Radiation Oncology at Fox Chase Cancer Center. His primary area of focus is the treatment of patients with genitourinary malignancies. He has extensive training and experience in intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT) and brachytherapy techniques. His research interests include novel and improved ways to deliver radiation therapy.

Dr. Hallman earned his medical degree as well as a doctorate in cell and molecular pharmacology and experimental therapeutics from the Medical University of South Carolina in Charleston. He completed his residency in radiation oncology at Fox Chase Cancer Center.
↖ read less

0 Comments